Posted: Thu Oct 01, 2009 9:10 pm Post subject: Neopharma Receives Manufacturing Approval for Oseltamivir BR
01 Oct 2009 - Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, announced it has received clearance from the UAE Ministry of Health for the production of an antiviral medication Oseltamivir BR Flu. The approval comes at a time when the entire region is stepping up efforts to tackle the H1N1 pandemic. The drug is a potential choice to prevent and treat H1N1 flu in the region.
His Excellency Abdulla Humaid Al Mazroei, Vice-Chairman, Neopharma, and Dr.B.R. Shetty, Managing Director and CEO, thanked the UAE Ministry of Health on behalf of the Board of Directors of the company.
Dr. Shetty said: "The endorsement for the antiviral drug to be manufactured by Neopharma reflects the strong support of the Ministry of Health for the vision of the UAE leadership to create a self-sustaining community. As a leading manufacturer of life-saving drugs, we believe it is our responsibility to play a vital role in helping the community at this critical juncture.
Neopharma's Oseltamivir BR Flu is the outcome of a joint venture with Hetero Drugs Ltd and is the first in a series of major life-saving drugs the company plans to produce over the next few years.
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum